Valuation Medtide Inc.

Stocks

Market Closed - Hong Kong S.E. 12:08:08 21/08/2026 +04			5-day change	1st Jan Change
23.34 ^HKD	-0.43%		+8.86%	-23.43%

07-31	Medtide Names CFO	MT
07-31	Medtide Inc. Announces Appointment of Ding Lijun as Chief Financial Officer, Effective July 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	3,884	2,838	-	-
Change	-	-26.93%	-	-
Enterprise Value (EV) ¹	3,027	2,144	2,035	1,924
Change	-	-29.15%	-5.09%	-5.49%
P/E	-	-	-	-
PBR	2.31x	1.48x	1.28x	1.1x
PEG	-	-	-	-
Capitalization / Revenue	6.81x	4.46x	3.52x	2.88x
EV / Revenue	5.31x	3.37x	2.52x	1.95x
EV / EBITDA	12.6x	8.04x	5.78x	4.58x
EV / EBIT	14.2x	9.24x	6.72x	5.11x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-	-	-	-
Distribution rate	-	-	-	-
Net sales ¹	570.1	635.6	807.3	984.9
EBITDA ¹	240.2	266.9	352	420.2
EBIT ¹	212.4	232	302.7	376.2
Net income	-	-	-	-
Net Debt ¹	-857.2	-693.3	-802.4	-914.2
Reference price ²	27.39	20.01	20.01	20.01
Nbr of stocks (in thousands)	141,800	141,800	-	-
Announcement Date	30/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MEDTIDE INC.	-	4.14x	9.86x	-.--%	424M
LONZA GROUP AG	34.4x	6.13x	18.24x	0.93%	51.22B
REVOLUTION MEDICINES, INC.	-21.71x	301.09x	-22.35x	-.--%	45.38B
BEONE MEDICINES AG	48.36x	5.61x	30.68x	-.--%	41.97B
IQVIA HOLDINGS INC.	32.97x	3.21x	13.87x	-.--%	42.15B
CELLTRION, INC.	29.48x	8.52x	21.54x	0.39%	31.95B
MEDPACE HOLDINGS, INC.	34.84x	5.71x	25.97x	-.--%	17.1B
EUROFINS SCIENTIFIC SE	24.28x	2.11x	9.12x	1.11%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.97x	4.1x	15.89x	-.--%	13.91B
Average	32.57x	37.85x	13.65x	0.27%	28.76B
Weighted average by Cap.	27.77x	57.21x	12.69x	0.3%